Difference between revisions of "I-123 Biomarker Committee"
Jump to navigation
Jump to search
m (→Round 6) |
|||
| Line 23: | Line 23: | ||
====Round 6==== | ====Round 6==== | ||
| + | *[[Media:Multi-center Phantom Study to Characterize Bias and Precision of Quantitative I-123 SPECT.pdf | Project (V) Multi-center Phantom Study to Characterize Bias and Precision of Quantitative I-123 SPECT (University of Michigan)]] | ||
| + | *[[Media:x.pdf | Project (X) x (Johns Hopkins University)]] | ||
Revision as of 16:39, 25 March 2019
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- Secretary: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD